Liposomes produced by reverse phase evaporation: In vitro and in vivo efficacy of diminazene aceturate against Trypanosoma evansi

Parasitology

Volumn 141, Issue 6, 2014, Pages 761-769

  Oliveira, Camila Belmonte ^a   Rigo, Lucas Almeida ^b   Rosa, Luciana Dalla ^a   Gressler, Lucas Trevisan ^a   Zimmermann, Carine Eloise Prestes ^a   Ourique, Aline Ferreira ^b   Da Silva, Aleksandro Schafer ^c   Miletti, Luiz C ^c   Beck, Ruy Carlos Ruver ^b   Monteiro, Silvia Gonzalez ^a  

^a Departamento de Microbiologia e Parasitologia da UFSM   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c SANTA CATARINA STATE UNIVERSITY   (Brazil)

Author keywords

diamidines; Nanotechnology; trypanosomosis

Indexed keywords

DIMINAZENE ACETURATE; GANAZEG; LIPOSOME; UNCLASSIFIED DRUG; ANTITRYPANOSOMAL AGENT; DIMINAZENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; DRUG FORMULATION; ENCAPSULATION; EVAPORATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MORTALITY; NONHUMAN; PARTICLE SIZE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; REVERSE PHASE EVAPORATION; SINGLE DRUG DOSE; TRYPANOSOMA; TRYPANOSOMA EVANSI; TRYPANOSOMIASIS; TRYPOMASTIGOTE; COMPARATIVE STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARASITEMIA; REVERSE MICELLE; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; MEDICINAL CHEMISTRY; NANOTECHNOLOGY; PARASITOLOGY; WISTAR RAT;

ANIMALIA; TRYPANOSOMA EVANSI;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIMINAZENE; LIPOSOMES; MALE; NANOTECHNOLOGY; RATS, WISTAR; TRYPANOCIDAL AGENTS; TRYPANOSOMA; TRYPANOSOMIASIS;

EID: 84898481951     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182013002114     Document Type: Article

References (38)

1. Alving, C.R. and Richards, R.L. (1990). Liposomes containing liquid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. Immunology Letters 24, 275-280.
2. Anene, B. M., Onah, D. N. and Nawa, Y. (2001). Drug resistance in pathogenic African trypanosomes: what hopes for the future? Veterinary Parasitology 96, A83-A100.
3. Atsriku, C., Watso, D. G., Tettey, J. N. A., Grant, M.H. and Skellern, G. G. (2002). Determination of diminazene aceturate in pharmaceutical formulations by HPLC and identification of related substances by LC/MS. Journal of Pharmaceutical and Biomedical Analysis 30, 979-986.
4. Badiee, A., Jaafari, M. R. and Khamesipour, A. (2007). Leishmania major: immune response in BALB/c mice immunized with stree-inducible protein 1 encapsulated in liposomes. Experimental Parasitology 115, 127-134.
5. Baltz, T., Baltz, D., Giroud, C. and Crockett, J. (1985). Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO Journal 4, 1273-1277.
6. Batista, C. M. (2007). Lipossomas e suas aplicações terapêuticas: Estado da arte. Revista Brasileira de Ciências Farmacêuticas 43, 167-179.
7. Brender, G. C., Pugh, D.M., Bywater, R. J. and Jenkins, W.L. (1991). Veterinary Applied Pharmacology & Therapeutics, 5th Edn. Ballière Tindall, London, UK.
8. Campbell, M., Prankerd, R. J., Davie, A. S. and Charman, W. N. (2004). Degradation of berenil (diminazene aceturate) in acidic aqueous solution. Journal of Pharmacy and Pharmacology 56, 1327-1332.
9. Colpo, C. B., Monteiro, S. G., Stainki, D.R., Colpo, E. T. B. and Henriques, G. B. (2005). Infecção Natural por Trypanosoma evansi em cão no Rio Grande do Sul. Ciência Rural 35, 717-719.
10. Dalla Rosa, L., Da Silva, A., Gressler, L.T., Oliveira, C.B., Dambrós, M. G., Miletti, L.C., França, T. R., Lopes, S. T. A., Samara, Y., Veiga, M. L. and Monteiro, S. G. (2013). Cordycepin (3′-deoxyadenosine) pentostatin (deoxycoformycin) combination treatment of mice experimentally infected with Trypanosoma evansi. Parasitology 1, 1-9.
11. Da Silva, A. S., Doyle, R. L. and Monteiro, S. G. (2006). Método de contenção e confecção de esfregaço sanguíneo para pesquisa de hemo-parasitas em ratos e camundongos. Revista da Faculdade de Zootecnia, Veterinária e Agronomia 13, 83-87.
12. Dávila, A. M. R., Souza, S. S., Campos, C. and Silva, R. A. (1999). The seroprevalence of equine trypanosomosis in the Pantanal. Memórias do Instituto Oswaldo Cruz 94, 199-202.
13. Doyle, R. L., Da Silva, A. S., Monteiro, S.G., Santurio, J. M. and Graça, D. L. (2007). Eficácia de medicamentos no controle da infecção experimental por Trypanosoma evansi em ratos. Acta Scientiae Veterinariae 35, 67-71.
14. Frézard, F., Schettini, D. A., Rocha, O. G. and Demicheli, C. (2005). Lipossomas: propriedades físico-químicas e farmacológicas, aplicações na quimioterapia à base de antimónio. Química Nova 28, 511-518.
15. Gillingwater, K., Kumar, A., Mohamed, A. I., Arafa, K. R., Stephens, C. E., Boykin, D. W., Tidwell, R.R. and Brun, R. (2010). In vitro activity and preliminary toxicity of various diamidine compounds against Trypanosoma evansi. Veterinary Parasitology 169, 264-272.
16. Gomes-Cardoso, L., Echevarria, A., Aguiar-Alves, F., Jansen, A. M. and Leon, L. L. (1999). Amidine derivatives are highly effective against Trypanosoma evansi trypomastigotes. Microbios 100, 181-187.
17. Howes, F., Da Silva, A.S., Athayde, C.L., Costa, M.M., Corrêa, M. M. B., Tavares, K. C. S., Miletti, L. C., Lopes, S. T.A., Amaral, A. S. and Schmidt, C. (2011). A new therapeutic protocol for dogs infected with Trypanosoma evansi. Acta Scientiae Veterinariae 39, 1-4.
18. Immordino, M. L., Brusa, P., Arpicco, S., Stella, B., Dosio, F. and Cattel, L. (2003). Preparation, characterization, cytotoxicity and pharma-cokinetics of liposomes containing docetaxel. Journal of Controlled Release 91, 417-429.
19. Joshi, P. P., Shegokar, V. R., Powar, R. M., Herder, S., Katti, R., Salkar, H. S., Dani, V.S., Bhargava, A., Jannin, J. and Truc, P. (2005). Human trypanosomosis caused by Trypanosoma evansi in India: the first case report. American Journal of Tropical Medicine and Hygiene 73, 491-495.
20. Kaminsky, R. and Brun, R. (1998). In vitro and in vivo activities of trybizine hydrochloride against various pathogenic trypanosome species. Antimicrobial Agents and Chemotherapy 42, 2858-2862.
21. Kroubi, M., Daulouede, S., Karembe, H., Jallouli, Y., Howsam, M., Mossalayi, D., Vincendeau, P. and Betbeder, D. (2010). Development of a nanoparticulate formulation of diminazene to treat African trypanoso-miasis. Nanotechnology 21, 1-8.
22. Lonsdale-Eccles, J. D. and Grab, D. J. (2002). Trypanosome hydrolases and the blood-brain barrier. Trends in Parasitology 18, 17-19.
23. Lopez-Berestein, G. (1987). Liposomes as carriers of antimicrobial agents. Antimicrobial Agents and Chemotherapy 31, 675-678.
24. Mamot, C., Drummond, D. C., Hong, K., Kirpotin, D. B. and Park, J. W. (2003). Liposome-based approaches to overcome anticancer drug resistance. Drug Research 6, 271-279.
25. Masocha, W., Rottenberg, M. E. and Kristensson, K. (2007). Migration of African trypanosomes across the blood-brain barrier. Physiology and Behavior 92, 110-114.
26. Mertins, O., Sebben, M., Pohlmann, A. R. and Silveira, N. P. (2005). Production of soybean phosphatidylcholine-chitosan nanovesicles by reverse phase evaporation: a step by step study. Chemistry and Physics of Lipids 138, 29-37.
27. Peregrine, A. S. (1994). Chemotherapy and delivery systems: haemo-parasites. Veterinary Parasitology 54, 223-248.
28. Peregrine, A. S. and Mamman, M. (1993). Pharmacologyof diminazene: a review. Acta Tropica 54, 185-203.
29. Polozova, A., Yamazaki, A., Brash, J. L. and Winnik, F.M. (1999). Effect of polymer architecture on the interactions of hydrophobically-modified poly-(N-isopropylamides) and liposomes. Colloids and Surfaces A: Physicochemical and Engineering Aspects 147, 17-25.
30. Romero, E. L. and Morilla, M. J. (2010). Nanotechnological approaches against Chagas disease. Advanced Drug Delivery Reviews 62, 576-588.
31. Silva, R.A. M. S., Seidl, A., Ramirez, L. and Dávila, A. M. R. (2002). Trypanosoma evansi e Trypanosoma vivax: Biologia, Diagnóstico e controle, Corumbá, Embrapa Pantanal.
32. Souto-Padrón, T., Carvalho, T. U., Chiari, E. and Souza, W. (1984). Further studies on the cell surface charge of Trypanosoma cruzi. Acta Tropica 41, 215-225.
33. Tachibana, H., Yoshihara, E., Kaneda, Y. and Nakae, T. (1988). In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes. Antimicrobial Agents and Chemotherapy 32, 966-970.
34. Tuntasuvan, D., Jarabrum, W., Viseshakul, N., Mohkaew, K., Borisutsuwan, S., Theeraphan, A. and Kongkanjana, N. (2003). Chemotherapy of surra in horses and mules with diminazene aceturate. Veterinary Parasitology 110, 227-233.
35. Ventura, R. M., Takeda, G. F., Silva, R. A. M. S., Nunes, V. L. B., Buck, G. A. and Teixeira, M. M. G. (2002). Genetic relatedness among Trypanosoma evansi stocks by random amplification of polymorphic DNA and evaluation of a synapomorphic DNA fragment for species-specific diagnosis. International Journal for Parasitology 32, 53-63.
36. Yongsheng, Y., Yongchun, O., Chengmai, R., Yuanguo, C. and Fenqin, Z. (1996). Trypanocidal value of liposomal diminazene in experimental Trypanosoma brucei evansi infection in mice. Veterinary Parasitology 95, 349-352.
37. Yoshihara, E., Tachibana, H. and Nakae, T. (1987). Trypanocidal activity of the stearylamine-bearing liposome in vitro. Life Science 40, 2153-2159.
38. Zanette, R. A., Da Silva, A. S., Costa, M. M., Monteiro, S. G., Santurio, J. M. and Lopes, S. T. A. (2008). Ocorrência de Trypanosoma evansi em eqüinos no município de Cruz Alta, RS, Brasil. Ciência Rural 38, 1468-1471.